Please provide your email address to receive an email when new articles are posted on . The FDA launched a new online dashboard for reporting adverse events related to cosmetic products. This ...
Health care workers face adverse events daily. These events include secondary trauma, occupational trauma, unexpected death or injury, moral injury, medical error and ...
This study aimed to empirically analyze gastrointestinal adverse events associated with Lenvatinib monotherapy and its combination with Pembrolizumab using FDA FAERS data (January 2015-December 2023), ...
The FDA Adverse Event Reporting System (FAERS) contains reports from health care professionals, consumers, and manufacturers on adverse events, serious medication errors, and product quality ...
Triptorelin, a gonadotropin-releasing hormone(GnRH) agonist, is approved by the US Food and Drug Administration(FDA) for treating advanced prostate cancer ...
The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system. In an effort to modernize and provide transparency on ...
A new FDA adverse events monitoring system combines seven different databases across the spread of the agency's sectors, which together has cost the FDA $37 million yearly to operate. (Stock Photo ) ...
Previously, information in the FDA's FAERS dashboard was updated on a quarterly basis. (Photo By Al Drago/CQ Roll Call) As Department of Health and Human Services (HHS) and FDA leadership continue to ...
Access to patient-reported outcome (PRO) data significantly improved providers' consistency in assessing adverse events in patients with cancer, with the greatest improvements observed for ...
The FDA has received hundreds of adverse event reports after people used compounded GLP-1 drugs for weight loss. Compounded GLP-1 drugs aren’t reviewed by the FDA for safety or effectiveness. The FDA ...
Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...
The US Food and Drug Administration (FDA) announced it is unifying its various adverse reporting systems into a single system called the Adverse Event Monitoring System (AEMS). The agency said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results